Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity | Elucida Research

top of page

FINAL FILE - ELUCIDA LOGO_Black.researchlogo.condensed.png

Rofecoxib increases susceptibility of human LDL and membrane lipids to oxidative damage: a mechanism of cardiotoxicity

Journal of Cardiovascular Pharmacology

47 Suppl 1:S7-14

bottom of page